The biopharma firm will issue 1.35M ADSs at $2.78 each and warrants for up to 2.02M additional shares.
BioLineRx announced a registered direct offering and private placement to raise $3.75M in gross proceeds. The company will sell 1.35 million American Depositary Shares (ADSs) at $2.78 per share, alongside warrants covering up to 2.02 million additional ADSs at the same price.
The offering aims to bolster the company’s capital position without disclosing prior fundraising rounds or consensus expectations. No immediate market reaction was reported following the announcement.
Proceeds are expected to support ongoing operations and development initiatives, though specific allocations were not detailed.